Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00880_DB01143_nanopub.RAeYNOi_U2xiI7YXbzMshGfFyowZLvqIuILm13at41I5c#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00880_DB01143 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00880_DB01143 label "DDI between Chlorothiazide and Amifostine - Antihypertensives may enhance the hypotensive effect of amifostine. When amifostine is used at doses recommended for chemotherapy, antihypertensive medications should be withheld for 24 hours prior to amifostine administration to avoid excessive hypotension during or immediately after infusion. If antihypertensive therapy can not be withheld, then that patient should not receive amifostine. Caution is recommended when using amifostine at the lower doses recommended for radiotherapy, but routine interruption of antihypertensive therapy is not recommended in these patients. [drugbank_resource:DB00880_DB01143]" assertion.
- drugbank_resource:DB00880_DB01143 identifier "drugbank_resource:DB00880_DB01143" assertion.
- drugbank_resource:DB00880_DB01143 title "DDI between Chlorothiazide and Amifostine - Antihypertensives may enhance the hypotensive effect of amifostine. When amifostine is used at doses recommended for chemotherapy, antihypertensive medications should be withheld for 24 hours prior to amifostine administration to avoid excessive hypotension during or immediately after infusion. If antihypertensive therapy can not be withheld, then that patient should not receive amifostine. Caution is recommended when using amifostine at the lower doses recommended for radiotherapy, but routine interruption of antihypertensive therapy is not recommended in these patients." assertion.
- drugbank:DB00880 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00880_DB01143 assertion.
- drugbank:DB01143 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00880_DB01143 assertion.